Rockwell Medical, Inc. (RMTI): Price and Financial Metrics


Rockwell Medical, Inc. (RMTI): $0.57

0.01 (+1.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RMTI POWR Grades


  • RMTI scores best on the Sentiment dimension, with a Sentiment rank ahead of 70.95% of US stocks.
  • The strongest trend for RMTI is in Value, which has been heading down over the past 52 weeks.
  • RMTI ranks lowest in Quality; there it ranks in the 9th percentile.

RMTI Stock Summary

  • RMTI has a market capitalization of $53,516,662 -- more than approximately just 7.93% of US stocks.
  • In terms of volatility of its share price, RMTI is more volatile than 92.68% of stocks we're observing.
  • Rockwell Medical Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -61.58%, greater than the shareholder yield of only 4.49% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Rockwell Medical Inc are VIVO, ULBI, FARO, OSPN, and CTS.
  • Visit RMTI's SEC page to see the company's official filings. To visit the company's web site, go to www.rockwellmed.com.

RMTI Valuation Summary

  • In comparison to the median Healthcare stock, RMTI's EV/EBIT ratio is 106.48% lower, now standing at -1.9.
  • RMTI's price/earnings ratio has moved up 5.5 over the prior 243 months.
  • RMTI's price/sales ratio has moved up 0.1 over the prior 243 months.

Below are key valuation metrics over time for RMTI.

Stock Date P/S P/B P/E EV/EBIT
RMTI 2021-08-31 1.0 3.4 -1.9 -1.9
RMTI 2021-08-30 1.0 3.4 -1.9 -1.9
RMTI 2021-08-27 1.0 3.4 -1.9 -1.9
RMTI 2021-08-26 1.1 3.5 -2.0 -2.0
RMTI 2021-08-25 1.0 3.4 -1.9 -1.9
RMTI 2021-08-24 1.0 3.3 -1.9 -1.9

RMTI Growth Metrics

  • The year over year cash and equivalents growth rate now stands at -4.61%.
  • The 2 year cash and equivalents growth rate now stands at 1040.9%.
  • Its year over year net cashflow from operations growth rate is now at -25.48%.
Over the past 67 months, RMTI's revenue has gone up $5,703,298.

The table below shows RMTI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 61.054 -30.91971 -32.165
2021-03-31 61.81297 -35.59757 -30.65754
2020-12-31 62.197 -29.641 -30.89
2020-09-30 62.52284 -26.37259 -29.52871
2020-06-30 62.65008 -27.63042 -30.03378
2020-03-31 61.5999 -28.36931 -33.43342

RMTI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RMTI has a Quality Grade of D, ranking ahead of 9.74% of graded US stocks.
  • RMTI's asset turnover comes in at 0.825 -- ranking 30th of 681 Pharmaceutical Products stocks.
  • IMGN, PTE, and BCDA are the stocks whose asset turnover ratios are most correlated with RMTI.

The table below shows RMTI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.825 0.014 -0.801
2021-03-31 0.850 0.033 -0.675
2020-12-31 0.863 0.044 -0.730
2020-09-30 0.981 0.055 -0.790
2020-06-30 1.151 0.049 -0.908
2020-03-31 1.139 0.048 -1.191

RMTI Price Target

For more insight on analysts targets of RMTI, see our RMTI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.00 Average Broker Recommendation 1.5 (Moderate Buy)

RMTI Stock Price Chart Interactive Chart >

Price chart for RMTI

RMTI Price/Volume Stats

Current price $0.57 52-week high $1.98
Prev. close $0.56 52-week low $0.54
Day low $0.56 Volume 284,800
Day high $0.58 Avg. volume 1,334,050
50-day MA $0.61 Dividend yield N/A
200-day MA $0.95 Market Cap 53.47M

Rockwell Medical, Inc. (RMTI) Company Bio


Rockwell Medical is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. The company was founded in 1995 and is based in Wixom, Michigan.


RMTI Latest News Stream


Event/Time News Detail
Loading, please wait...

RMTI Latest Social Stream


Loading social stream, please wait...

View Full RMTI Social Stream

Latest RMTI News From Around the Web

Below are the latest news stories about Rockwell Medical Inc that investors may wish to consider to help them evaluate RMTI as an investment opportunity.

Hemodialysis Powder Solution Market Growth, Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis And Forecasts 2029 Baxter, Rockwell Medical, Fresenius

The research study presented here is an intelligent take on the global Hemodialysis Powder Solution Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of

OpenPR | September 10, 2021

Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

WIXOM, Mich., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that members of its executive management team are scheduled to present at the H.C. Wainwright 23 rd Annual Global Investment Conference, being held virtually September 13-15, 2021.

Intrado Digital Media | September 9, 2021

Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

WIXOM, Mich., Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (Rockwell Medical or the Company), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that a majority of the independent directors serving on the Companys Board of Directors approved the grant of an option to purchase 350,000 shares of the Companys common stock to Megan C. Timmins, the Companys Senior Vice President, General Counsel and Secretary (the Inducement Grant). The Inducement Grant has been granted outside of the Companys 2018 Long Term Incentive Plan (Plan), but remains subject to the terms and conditions of such Plan. The Inducement Grant was granted as an inducemen...

Intrado Digital Media | August 19, 2021

Rockwell Medical, Inc. (NASDAQ:RMTI) Just Reported And Analysts Have Been Cutting Their Estimates

Rockwell Medical, Inc. ( NASDAQ:RMTI ) missed earnings with its latest second-quarter results, disappointing...

Yahoo | August 19, 2021

7 Penny Stocks to Buy if You Want Potential Multibaggers

Here's a list of interesting penny stocks to buy that have lucrative prospects if you're willing to risk it for tremendous upside.

Steve Booyens on InvestorPlace | August 16, 2021

Read More 'RMTI' Stories Here

RMTI Price Returns

1-mo -7.47%
3-mo -24.27%
6-mo -46.23%
1-year -42.48%
3-year -86.84%
5-year -90.64%
YTD -43.56%
2020 -58.61%
2019 7.96%
2018 -61.17%
2017 -11.15%
2016 -36.04%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0281 seconds.